Latest news with #Collegium
&w=3840&q=100)
Business Standard
20-05-2025
- Politics
- Business Standard
'Transfer meant to harass me': MP HC Justice DV Ramana in farewell speech
Justice DV Ramana of the Madhya Pradesh High Court did not pull any punches in his farewell speech on Tuesday, saying that his transfer to the state was done with an intention to harass him. Justice Ramana, who was appointed to the Madhya Pradesh High Court in November 2023, later submitted representations twice to the Supreme Court Collegium requesting a transfer, citing his wife's medical condition — PNES, a severe infirmity in the brain due to COVID pandemic. He alleged, however, that the Collegium neither responded to nor acted on his requests. "But the representation was neither considered nor rejected. During the tenure of the then Chief Justice, I sent another representation that too was neither rejected nor considered. I received no response. A judge like me expects positive humanitarian consideration. I was disheartened and deeply pained," Justice Ramana said, as quoted by Bar and Bench. "Anyway, my transfer order seems to have been issued with ill intention and to harass me. I was transferred from my home state for obvious reasons. I am happy to satisfy for their ego. Now they are retired. God does not forgive, nor forgets. They will also suffer in other mode," Justice Ramana said. The Collegium that recommended his transfer comprised then Chief Justice of India DY Chandrachud and Justices Sanjay Kishan Kaul, Sanjiv Khanna, BR Gavai and Surya Kant. The Collegium rejected Justice Ramana's request stating that it "does not find any merit in the requests made by him". 'It did not rattle me' Apart from mentioning his struggle with the transfer, Justice Ramana also said that he received immense affection, support, and collaboration from both the judges and members of the Bar in Jabalpur and Indore. "My transfer was expected to rattle me, but it did not. I did the opposite. I have made long, lasting contributions in each of the two states - State of Andhra Pradesh and State of Madhya Pradesh. I had an opportunity to serve in the land of Amravati, Krishna and Godavari and Narmada. I have truly served justice. I am blessed for these opportunities," he added.
Yahoo
19-05-2025
- Business
- Yahoo
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Mizuho Neuro & Ophthalmology Summit 2025Panel Presentation: Wednesday, May 21, 2025, at 11:25 a.m. ET Jefferies Global Healthcare ConferencePresentation: Thursday, June 5, 2025, at 1:25 p.m. ET The presentation at Jefferies Global Healthcare Conference will be webcast live and can be accessed from the Investors section of the Company's website: A replay of the webcast will be archived on the Company's website for 90 days following the presentation. About Collegium Pharmaceutical, is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM®, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium's strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company's website at Investor Contacts:Ian KarpHead of Investor Relationsir@ Danielle JesseDirector, Investor Relationsir@ Media Contact:Cheryl WheelerHead of Corporate Communicationscommunications@
NDTV
13-05-2025
- Politics
- NDTV
Legacy Of Ex-Chief Justice Khanna, Who Did "What Was Expected Of Him"
NEW DELHI: Chief Justice of India Sanjiv Khanna, the country's 51st CJI -- retired today after a six-month tenure which despite its brief length, was significant. Known for his camera-shy personality among journalists, Justice Khanna is leaving behind a legacy. During a recent interaction with journalists, when this reporter mentioned writing "expect the unexpected" from him in a column, Justice Khanna just laughed and said, "No. I have only done what was expected of me". His most significant contribution was the transparency brought in at the higher level of judiciary - be it through the voluntary public disclosure of assets by Supreme Court judges or the appointment of judges by the Collegium. The first thing he did after assuming office was to stop oral mention of cases in his court room. The message was clear - no optics, write a mail or move a slip if there is something urgent. He ensured that his silence was never mistaken for weakness. He sent a clear message to the Executive and Legislature when Nishikant Dubey and Vice President Jagdeep Dhankar questioned the top court over its verdict in the Wakf and Tamil Nadu Governor cases. "Can't shake public's trust in us despite clear intent," Justice Khanna had replied to Mr Dubey while refusing to take contempt action against him, when the BJP MP accused him of causing civil wars in country. While Mr Dubay's comments reflect a tendency to attract attention by casting aspersions on the Supreme Court and its judges, "We are of the firm opinion that courts are not as fragile as flowers to wither and wilt under such ludicrous statements," he said. At the same time, he clearly said that "hate speech must be dealt with an iron hand" and warned against spreading communal disharmony. After Mr Dhankar's remarks regarding the role of legislature and executive, Justice Khanna, without naming anyone, reiterated that the Constitution is Supreme. Refusing to bow under any pressure from the Left, Right and the Centre, Justice Khanna kept it only about law. When violence erupted in Sambhal over Jama Masjid, he put a freeze on the registration of any fresh suit under Places of Worship Act till the time court decided on the legality of the law. The tension over Gyanvapi-Kashivishwanath dispute, the Shahi-Idgah- Krishna Janmabhoomi dispute, the Bhojshala-Kamal Maula mosque dispute and many other temple-mosque disputes emerging across the country and causing communal tension were put on the back-burner. Similarly, when the Waqf Amendment law was challenged in the top court, without giving in to any pressure, he focused on the question of law and proposed an interim stay calling the case "exceptional". Despite several appeals from Solicitor General Tushar Mehta against an interim stay, Justice Khanna maintained that "nothing changes on ground till we decide the case". Justice Khanna, replying to an argument by the Solicitor General defending the inclusion of non-Muslims in Waqf councils and boards, said judges lose religion when they sit on the bench. He authored a separate concurring opinion in the landmark Electoral Bond judgment. In it, he cited detailed data to convey that the data submitted in the Supreme Court on the Electoral Bonds Scheme suggests that around 94 per cent of electoral bonds purchased since the scheme was launched in value terms were found to be for Rs.1 crore. This, in turn, suggests that corporates or individuals with high net worth were main donors in the electoral bonds scheme, he concluded. "Data show that more than 50 per cent of the bonds in number, and 94 per cent of the bonds in value terms were for Rs 1 crore. This is indicative of the quantum of corporate funding through the anonymous bonds," the judge noted. When the real data was made public by SBI, it came to light that his analysis was not only correct but also crucial in identifying the possibility of quid pro quo through the scheme. Regarding matrimonial dispute, he made a significant contribution to invoke special powers of Supreme Court under Article 142 to grant divorce. In his farewell speech he summed it up "The job of the judge is not to dominate the courtroom but neither to surrender." On presuming office, Justice Khanna had said his priority would be reducing pendency. As he stepped down today, he said for the first time in several years, "We have achieved a case clearance ratio of more than 100 per cent reaching 106 per cent. The Supreme Court disposed of more cases than were filed, allowing us to reduce backlogs". His successor Chief Justice BR Gavai, while giving his farewell speech, noted that Justice Khanna's tenure was not about making a spectacle or noise for the sake of attention. It was about encouraging changes within the judiciary, so that the system not only changes but it evolves. In his farewell speech, he summed it up: "The job of the judge is not to dominate the courtroom but neither to surrender." On presuming office, he said his priority would be reducing pendency, today he stepped down from office on this note: "For the first time in several years we have achieved a case clearance ratio of more than 100 percent reaching 106 percent. The supreme court disposed of more cases than the cases were filed allowing us to reduce the backlogs". His successor Chief Justice BR Gavai said Justice Khanna's tenure was "not about making a spectacle or noise for the sake of attention, it was about encouraging changes within the judiciary, so that the system not only changes but it evolves".
India Today
13-05-2025
- Politics
- India Today
A voice from the bench, not the podium: CJI Sanjiv Khanna's quiet legacy
The brief tenure of Sanjiv Khanna as the Chief Justice of India, who retired on Tuesday, is a story of quiet resolve and understated transformation. Justice BR Gavai will take over as the next Chief Justice of India on Wednesday.A private, deeply introspective judge with no prior experience as a High Court Chief Justice and just a six-month tenure at the Supreme Court's helm, Chief Justice Khanna defied many assumed his time in office would be transitional, he delivered with calm precision: steering sensitive cases, enhancing transparency, and reinforcing institutional accountability. His tenure is a testament to the idea that leadership is not always about duration, but about SANJIV KHANNA: MAN OF FEW WORDS Justice Khanna's tenure offers a compelling lesson in judicial philosophy - that silence, when paired with substance, can be powerful. Known for his quiet demeanour and minimal public presence, he rarely made headlines with speeches or commentary. Instead, he let his judicial work speak for an era driven by constant commentary and soundbites, CJI Khanna stood apart - choosing action from the bench over articulation outside it. He embodied the oft-cited judicial credo, "Judges must speak through their orders".As Chief Justice, he refrained from commenting on cases or issues in public forums, opting instead to make decisive interventions from the bench when the moment demanded ORDERS, BIG RIPPLESadvertisementJustice Khanna's hallmark was the use of precise, timely interim orders that addressed urgent issues while leaving the final judgments for another day. He showed that timed interim interventions can have a more far-reaching impact than lengthy notable example of this was an interim order passed by a bench led by him, staying the registration of fresh suits under the Places of Worship Act. The matter had lingered since 2021 before multiple benches, but under his leadership, the Supreme Court took a clear, firm stand - observing that lower courts should not entertain such disputes while the apex court was seized of the the recent Waqf law case, Justice Khanna clearly indicated that some provisions needed to be stayed while the challenge to the amendment was he refrained from issuing an official stay, his firm approach led the Centre to provide a clear assurance that these provisions would not be enforced in the MOVES AND TRANSPARENCYDuring the controversy around the proposed transfer of Justice Yashwant Varma, in whose residence an unaccounted cash pile was found, CJI Khanna took the significant step of releasing relevant Collegium details to the public - underscoring that in matters of public trust, clarity is the remedy, not silence and Collegium, under his leadership, on March 20, 2025, recommended Justice Varma's transfer, which was later approved by the Centre. Justice Khanna also withdrew judicial work assigned to Justice Varma during this the appointments front, he played a pivotal role in finalising key collegium recommendations. Under his leadership, 51 out of 103 proposed candidates were recommended for High Court judgeships, including 11 OBCs, 1 SC, 2 STs, 8 minorities, and 2 related to sitting/retired recommendations remain pending with the government. Notably, three Supreme Court judges were appointed during his term, including Justice Joymalya Bagchi, a future Chief Justice in the line of of the most transformative decisions during CJI Khanna's tenure was a full court resolution on April 1, 2025: all judges would mandatorily declare their assets upon assuming office, a step up from the earlier voluntary norm. By April 5, 2025, statements of assets were published on the Supreme Court also oversaw the publication of the complete judicial appointment process, including the role of the High Court Collegium, inputs from the states and Centre, and the Supreme Court Collegium's final decision, bringing unprecedented public access to this previously opaque data, such as whether nominees belong to any reserved category (SC/ST/OBC/Minority/Woman) or are related to any sitting/retired judges, has also been made available MANAGEMENTOn the administrative front, CJI Khanna ensured smoother case listings and effective court functioning. He continued the process of online mentioning of cases initiated by his predecessor, CJI DY Khanna also had a different way of hearing cases where multiple pleas are filed, including cases regarding the Places of Worship Act, Waqf Amendment Act etc. To ensure that cases are heard in a timely manner, he directed no further fresh pleas to be filed before court and, instead, intervention applications be JUDGMENTS AS JUDGEBefore assuming office as Chief Justice, Justice Khanna was part of several landmark decisions. He was on the five-judge bench that declared the Electoral Bond Scheme unconstitutional, reaffirming voters' right to led the bench that refused to mandate 100% VVPAT verification, upholding the current EVM-based voting system. He contributed a separate concurring opinion to the judgment that upheld the abrogation of Article 370, reinforcing the constitutional validity of the government's Watch IN THIS STORY#Supreme Court
Business Upturn
12-05-2025
- Business
- Business Upturn
Collegium Announces $25 Million Accelerated Share Repurchase Program
STOUGHTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has entered into an Accelerated Share Repurchase ('ASR') agreement with Jefferies LLC to repurchase $25 million of the Company's common stock. Collegium will execute the ASR as part of the $150 million share repurchase program authorized by its Board of Directors in January 2024. Upon completion of this ASR, Collegium will have $65 million remaining under the program. 'Collegium is off to a strong start in 2025 with first quarter revenues growing 23% year-over-year, driven by robust sales from our pain portfolio and a significant contribution from our rapidly growing ADHD medicine, Jornay PM®,' said Colleen Tupper, Chief Financial Officer. 'The Board's authorization of a $25 million ASR program reflects our strategic approach to capital allocation that balances driving sustained revenue growth while also returning capital to shareholders. We are confident in our future growth trajectory and remain committed to generating additional value as we invest in our key product growth drivers, expand our portfolio through disciplined business development, rapidly pay down debt and opportunistically repurchase shares.' Under terms of the agreement, Collegium will pay $25 million to Jefferies LLC and will receive an initial delivery of 692,281 shares, based on the $28.89 closing stock price of Collegium's common stock on May 9, 2025, representing approximately 80% of the total shares the Company expects to repurchase under the ASR agreement. The final number of shares repurchased will be based on the volume-weighted average prices of Collegium's common stock during the term of the ASR and subject to adjustments related to the terms and conditions of the ASR agreement. The final settlement of the ASR is expected to be completed no later than the third quarter of 2025. As of March 31, 2025, Collegium had approximately 32.1 million shares outstanding. About Collegium Pharmaceutical, Inc. Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium's strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company's website at Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. We may, in some cases, use terms such as 'predicts,' 'forecasts,' 'believes,' 'potential,' 'proposed,' 'continue,' 'estimates,' 'anticipates,' 'expects,' 'plans,' 'intends,' 'may,' 'could,' 'might,' 'should' or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Examples of forward-looking statements contained in this press release include, among others, statements related to current and future market opportunities for our products and our assumptions related thereto, expectations (financial or otherwise) and intentions, and other statements that are not historical facts. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results, performance, or achievements to differ materially from the company's current expectations, including risks relating to, among others: unknown liabilities; risks related to future opportunities and plans for our products, including uncertainty of the expected financial performance of such products; our ability to commercialize and grow sales of our products; our ability to manage our relationships with licensors; the success of competing products that are or become available; our ability to maintain regulatory approval of our products, and any related restrictions, limitations, and/or warnings in the label of our products; the size of the markets for our products, and our ability to service those markets; our ability to obtain reimbursement and third-party payor contracts for our products; the rate and degree of market acceptance of our products; the costs of commercialization activities, including marketing, sales and distribution; changing market conditions for our products; the outcome of any patent infringement or other litigation that may be brought by or against us; the outcome of any governmental investigation related to our business; our ability to secure adequate supplies of active pharmaceutical ingredient for each of our products and manufacture adequate supplies of commercially saleable inventory; our ability to obtain funding for our operations and business development; regulatory developments in the U.S.; our expectations regarding our ability to obtain and maintain sufficient intellectual property protection for our products; our ability to comply with stringent U.S. and foreign government regulation in the manufacture of pharmaceutical products, including U.S. Drug Enforcement Agency compliance; our customer concentration; and the accuracy of our estimates regarding expenses, revenue, capital requirements and need for additional financing. These and other risks are described under the heading 'Risk Factors' in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q and other filings with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Investor Contacts:Ian KarpHead of Investor Relations [email protected]
